Jane Street’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Sell
36,100
-65,400
-64% -$730K ﹤0.01% 8669
2026
Q1
$1.21M Sell
101,500
-186,000
-65% -$1.9M ﹤0.01% 6109
2025
Q4
$2.86M Sell
287,500
-122,800
-30% -$1.17M ﹤0.01% 4125
2025
Q3
$3.67M Sell
410,300
-448,100
-52% -$4.15M ﹤0.01% 3893
2025
Q2
$8.09M Sell
858,400
-93,700
-10% -$827K ﹤0.01% 2403
2025
Q1
$10.3M Buy
952,100
+591,800
+164% +$5.95M ﹤0.01% 1958
2024
Q4
$3.43M Buy
360,300
+146,200
+68% +$1.48M ﹤0.01% 3218
2024
Q3
$2.4M Buy
214,100
+121,300
+131% +$1.29M ﹤0.01% 4099
2024
Q2
$928K Buy
+92,800
New +$943K ﹤0.01% 5913
2022
Q4
Sell
-94,100
Closed -$1.77M 9041
2022
Q3
$1.77M Buy
+94,100
New +$1.93M ﹤0.01% 4400
2022
Q1
Sell
-16,100
Closed -$394K 10201
2021
Q4
$394K Buy
16,100
+1,200
+8% +$28.2K ﹤0.01% 7676
2021
Q3
$347K Buy
14,900
+3,500
+31% +$84.6K ﹤0.01% 7910
2021
Q2
$312K Buy
+11,400
New +$325K ﹤0.01% 8073

Other funds holding AHCO

Jane Street's AHCO Position: Q2 2026 in Review

Jane Street sold out of AdaptHealth (AHCO) in Q2 2026, closing a stake of 478,205 shares — an estimated $5.34M sold.

Jane Street first reported a position in AHCO in Q2 2020 and held it in 21 quarters. The position peaked at $18.6M in Q1 2023. 239 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Jane Street reported no remaining AdaptHealth position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 478,205 AdaptHealth shares in Q2 2026, an estimated $5.34M.
  • Jane Street first reported a position in AdaptHealth in Q2 2020 and held it in 21 quarters.
  • Jane Street's AdaptHealth position peaked at $18.6M in Q1 2023.
  • 239 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.